NCT04762082View on ClinicalTrials.gov

A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 1, 2025

Primary Completion Date

August 30, 2025

Study Completion Date

December 30, 2025

Conditions

Erectile Dysfunction

Interventions

DRUG

Tadalafil 10 MG

comparison of tadalafil gummy 10mg and tadalafil oral tablet 10mg

All Listed Sponsors

lead

Seattle Gummy Company

INDUSTRY